Loading organizations...
Loading organizations...
Biotechnology company developing immunotherapies for cancer treatment.
Eureka Therapeutics has raised $132.0M across 4 funding rounds.
Eureka Therapeutics has raised $132.0M in total across 4 funding rounds.
Eureka Therapeutics has raised $132.0M in total across 4 funding rounds.
Eureka Therapeutics's investors include Richard Klausner, C.K. Cheng, GP Capital, Yuan Capital, Harbinger Venture Management, Acorn Campus, Desert Spring Life Science Capital.
Eureka Therapeutics has raised $132.0M across 4 funding rounds. Most recently, it raised $45.0M Series E in March 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 17, 2020 | $45.0M Series E | Richard Klausner | |
| Jan 23, 2018 | $60.0M Series D | C.K. Cheng | GP Capital |
| Sep 23, 2014 | $21.0M Series C | Yuan Capital | |
| Nov 17, 2008 | $6.0M Other Equity | Harbinger Venture Management | Acorn Campus, Desert Spring Life Science Capital |